Christopher Ray Aker serves as Executive at Regulus Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Christopher Ray Aker has executed 17 insider transactions totaling $31.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 18, 2024 involved selling 5,468 shares valued at $6.5K.
Christopher Ray Aker currently holds 10,056 shares of Regulus Therapeutics Inc. (RGLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Ray Aker has been a net seller of RGLS stock. They have purchased $0 and sold $31.2K worth of shares.
Christopher Ray Aker's most recent insider trade was on Jan 18, 2024, when they sold 5,468 shares at $1.19 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 17, 2021 | RGLS | $765 | Sale | 860 | $0.89 | Discretionary |
| Feb 16, 2021 | RGLS | $1.4K | Sale | 828 | $1.72 | Discretionary |
| Nov 16, 2020 | RGLS | $456 | Sale | 876 | $0.52 | Discretionary |
| Aug 14, 2020 | RGLS | $532 | Sale | 872 | $0.61 | Discretionary |
| May 15, 2020 | RGLS | $573 | Sale | 909 | $0.63 | Discretionary |
| Feb 18, 2020 | RGLS | $737 | Sale | 888 | $0.83 | Discretionary |
| Jan 2, 2020 | RGLS | $2.2K | Sale | 2,239 | $0.97 | Discretionary |
| Nov 14, 2019 | RGLS | $533 | Sale | 833 | $0.64 | Discretionary |
| Oct 1, 2019 | RGLS | $1.6K | Sale | 2,346 | $0.68 | Discretionary |
| Aug 15, 2019 | RGLS | $494 | Sale | 899 | $0.55 | Discretionary |
| Jul 1, 2019 | RGLS | $2.9K | Sale | 2,225 | $1.31 | Discretionary |
| May 15, 2019 | RGLS | $9.8K | Sale | 6,950 | $1.41 | Discretionary |
| May 14, 2019 | RGLS | $0 | Award | 38,512 | $N/A | Discretionary |
| Apr 1, 2019 | RGLS | $2.7K | Sale | 2,710 | $0.98 | Discretionary |
| Feb 5, 2019 | RGLS | $0 | Award | 25,000 | $N/A | Discretionary |